or Try an Advanced Search...

    Cell Therapy Products Stocks List

    Symbol Grade Name % Change
    PLUR D Pluri Inc. -7.11
    LSTA D Lisata Therapeutics, Inc. -2.94
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Cell Therapy Life Sciences Stem Cell Acute Respiratory Distress Syndrome Angina Biopharmaceutical Chronic Kidney Disease Covid 19 Disease Emerging Technologies Graft Versus Host Disease Host Disease Inflammatory Radiation Regenerative Medicine Stem Cell Therapy Surgery Surgical Oncology Transplantation

    Cell Therapy Products Stocks Recent News

    Date Stock Title
    Nov 19 LSTA Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
    Nov 15 PLUR Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Cell Therapy Life Sciences Stem Cell Acute Respiratory Distress Syndrome Angina Biopharmaceutical Chronic Kidney Disease Covid 19 Disease Emerging Technologies Graft Versus Host Disease Host Disease Inflammatory Radiation Regenerative Medicine Stem Cell Therapy Surgery Surgical Oncology Transplantation
    Cell Therapy Products

    Cell therapy products are products that use living cells to treat or prevent a disease or condition. These products can be made from a patient's own cells, from cells from another person, or from cells that have been modified in the laboratory. Examples of cell therapy products include stem cell therapies, gene therapies, and tissue engineering products.

    Browse All Tags